^Ziegler MG, Lake CR, Kopin IJ. The sympathetic-nervous-system defect in primary orthostatic hypotension. N Engl J Med. 1977 Feb 10;296(6):293-7. doi: 10.1056/NEJM197702102960601. PMID 831126.
^Hale GM, Valdes J, Brenner M. The Treatment of Primary Orthostatic Hypotension. Ann Pharmacother. 2017 May;51(5):417-428. doi: 10.1177/1060028016689264. Epub 2017 Jan 16. PMID 28092986.
^Tzur, I., Izhakian, S., & Gorelik, O. (2019). Orthostatic hypotension: definition, classification and evaluation. Blood Pressure, 28(3), 146–156. https://doi.org/10.1080/08037051.2019.1604067
^Ricci F, De Caterina R, Fedorowski A. Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment. J Am Coll Cardiol. 2015 Aug 18;66(7):848-860. doi: 10.1016/j.jacc.2015.06.1084. PMID 26271068.
^Bhanu C, Nimmons D, Petersen I, Orlu M, Davis D, Hussain H, Magammanage S, Walters K. Drug-induced orthostatic hypotension: A systematic review and meta-analysis of randomised controlled trials. PLoS Med. 2021 Nov 9;18(11):e1003821. doi: 10.1371/journal.pmed.1003821. PMID 34752479; PMCID: PMC8577726.